A detailed history of Archford Capital Strategies, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Archford Capital Strategies, LLC holds 70,758 shares of PACB stock, worth $94,815. This represents 0.04% of its overall portfolio holdings.

Number of Shares
70,758
Previous 20,024 253.37%
Holding current value
$94,815
Previous $196,000 35.2%
% of portfolio
0.04%
Previous 0.04%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$3.52 - $9.59 $178,583 - $486,539
50,734 Added 253.37%
70,758 $265,000
Q4 2023

Jan 12, 2024

SELL
$5.97 - $10.36 $320,350 - $555,917
-53,660 Reduced 72.82%
20,024 $196,000
Q3 2023

Oct 27, 2023

SELL
$8.23 - $13.93 $1,333 - $2,256
-162 Reduced 0.22%
73,684 $615,000
Q2 2023

Aug 02, 2023

SELL
$9.97 - $14.05 $3,918 - $5,521
-393 Reduced 0.53%
73,846 $982,000
Q1 2023

Apr 18, 2023

BUY
$7.94 - $12.02 $6,034 - $9,135
760 Added 1.03%
74,239 $859,000
Q4 2022

Jan 26, 2023

SELL
$5.67 - $11.2 $52,067 - $102,849
-9,183 Reduced 11.11%
73,479 $0
Q3 2022

Oct 17, 2022

BUY
$3.93 - $8.57 $31,789 - $69,322
8,089 Added 10.85%
82,662 $480,000
Q2 2022

Jul 12, 2022

BUY
$4.02 - $10.43 $5,137 - $13,329
1,278 Added 1.74%
74,573 $330,000
Q1 2022

Apr 18, 2022

BUY
$8.43 - $20.9 $12,290 - $30,472
1,458 Added 2.03%
73,295 $693,000
Q4 2021

Jan 20, 2022

SELL
$19.26 - $30.08 $23,285 - $36,366
-1,209 Reduced 1.66%
71,837 $1.47 Million
Q3 2021

Oct 14, 2021

BUY
$24.86 - $35.02 $8,104 - $11,416
326 Added 0.45%
73,046 $1.87 Million
Q2 2021

Jul 23, 2021

BUY
$22.3 - $36.02 $57,712 - $93,219
2,588 Added 3.69%
72,720 $2.54 Million
Q1 2021

Apr 26, 2021

BUY
$26.38 - $51.15 $159,124 - $308,536
6,032 Added 9.41%
70,132 $2.3 Million
Q4 2020

Jan 19, 2021

BUY
$10.5 - $28.5 $73,500 - $199,500
7,000 Added 12.26%
64,100 $2.35 Million
Q3 2020

Oct 19, 2020

BUY
$3.61 - $9.87 $206,131 - $563,577
57,100 New
57,100 $564,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $301M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Archford Capital Strategies, LLC Portfolio

Follow Archford Capital Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Archford Capital Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Archford Capital Strategies, LLC with notifications on news.